To test this hypothesis, we analysed serum RANKL/OPG in women with breast cancer diagnosis but in the absence of a tumor in the breast - a similar scenario as in the UKCTOCS cohort close to breast cancer diagnosis. The gene discussed is TNFRSF11B; the disease is breast carcinoma.